NDC product
Rifadin IV NOVAPLUS
NDC 0068-0599 · Sanofi-Aventis U.S. LLC
Key facts
| Product NDC | 0068-0599 |
|---|---|
| Proprietary name | Rifadin IV NOVAPLUS |
| Labeler | Sanofi-Aventis U.S. LLC |
| Marketing category | NDA |
| Application number | NDA050627 |
| Marketing start | Feb 1, 2017 |
| Marketing end | Oct 31, 2025 |
| Listing certified through | Oct 31, 2025 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: